NYSE:ACRE - Ares Commercial Real Estate Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $15.13
  • Forecasted Upside: 0.43 %
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
▲ +0.16 (1.07%)

This chart shows the closing price for ACRE by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Ares Commercial Real Estate Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ACRE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ACRE

Analyst Price Target is $15.13
▲ +0.43% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Ares Commercial Real Estate in the last 3 months. The average price target is $15.13, with a high forecast of $16.50 and a low forecast of $13.50. The average price target represents a 0.43% upside from the last price of $15.06.

This chart shows the closing price for ACRE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 4 investment analysts is to buy stock in Ares Commercial Real Estate. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/5/2021Raymond JamesBoost Price TargetOutperform$15.00 ➝ $16.50Medium
4/30/2021BTIG ResearchReiterated RatingBuy$14.50Low
4/26/2021JPMorgan Chase & Co.Boost Price TargetNeutral$12.50 ➝ $13.50Low
3/17/2021Credit Suisse GroupBoost Price TargetOutperform$13.00 ➝ $16.00Low
2/25/2021Raymond JamesBoost Price TargetOutperform$12.00 ➝ $15.00High
2/2/2021BTIG ResearchInitiated CoverageBuy$13.50Low
12/4/2020Raymond JamesReiterated RatingBuy$11.00Low
11/20/2020Raymond JamesDowngradeStrong-Buy ➝ Outperform$12.00Low
6/29/2020Keefe, Bruyette & WoodsUpgradeMarket Perform ➝ Outperform$10.50Low
4/27/2020Credit Suisse GroupLower Price TargetOutperform$17.50 ➝ $9.00High
4/22/2020JMP SecuritiesLower Price TargetMarket Outperform$16.00 ➝ $10.00High
4/13/2020Raymond JamesLower Price TargetStrong-Buy$16.00 ➝ $11.00Medium
2/25/2020JPMorgan Chase & Co.Boost Price TargetNeutral$16.00 ➝ $16.50High
2/21/2020Credit Suisse GroupBoost Price TargetOutperform$16.00 ➝ $17.50Low
1/8/2020Credit Suisse GroupUpgradeNeutral ➝ Outperform$16.00Medium
1/11/2019Raymond JamesUpgradeOutperform ➝ Strong-BuyHigh
10/24/2018JPMorgan Chase & Co.Boost Price TargetNeutral ➝ Neutral$14.00 ➝ $14.50Medium
10/8/2018BTIG ResearchInitiated CoverageBuy ➝ Buy$15.00High
8/21/2018Credit Suisse GroupBoost Price TargetNeutral ➝ Neutral$14.00 ➝ $14.50High
7/30/2018JMP SecuritiesBoost Price TargetMarket Outperform ➝ Market Outperform$14.50 ➝ $15.00Low
7/23/2018Raymond JamesInitiated CoverageOutperformLow
7/23/2018JPMorgan Chase & Co.DowngradeOverweight ➝ NeutralLow
5/23/2018Bank of AmericaDowngradeBuy ➝ Hold$14.00Low
5/2/2018Bank of AmericaUpgradeUnderperform ➝ BuyHigh
1/9/2018B. RileyReiterated RatingBuy$14.00Low
11/2/2017B. RileyReiterated RatingBuyN/A
8/17/2017Keefe, Bruyette & WoodsSet Price TargetHold$14.00Low
8/10/2017JMP SecuritiesReiterated RatingOutperform$15.00 ➝ $14.50Medium
8/7/2017JMP SecuritiesBoost Price TargetMarket Outperform$14.00Low
8/4/2017Credit Suisse GroupReiterated RatingHoldHigh
6/9/2017Keefe, Bruyette & WoodsReiterated RatingHold$13.75Low
5/3/2017Keefe, Bruyette & WoodsReiterated RatingHold$13.75High
12/15/2016Bank of AmericaDowngradeNeutral ➝ UnderperformN/A
11/22/2016(FBRC)Boost Price TargetOutperform$14.00 ➝ $14.75N/A
11/4/2016JPMorgan Chase & Co.Reiterated RatingBuy$14.00N/A
9/14/2016(FBRC)Reiterated RatingBuy$13.00N/A
9/9/2016Credit Suisse GroupReiterated RatingHold$13.00N/A
8/11/2016CitigroupBoost Price TargetBuy$12.00 ➝ $14.00N/A
8/8/2016Credit Suisse GroupReiterated RatingHold$13.00N/A
8/5/2016Keefe, Bruyette & WoodsBoost Price TargetMarket Perform$12.00 ➝ $13.00N/A
(Data available from 7/25/2016 forward)
Ares Commercial Real Estate logo
Ares Commercial Real Estate Corporation, a specialty finance company, originates and invests in commercial real estate (CRE) loans and related investments in the United States. It provides a range of financing solutions for the owners, operators, and sponsors of CRE properties. The company originates senior mortgage loans, subordinate debt products, mezzanine loans, real estate preferred equity investments, and other CRE investments, including commercial mortgage backed securities. Ares Commercial Real Estate Corporation has elected and qualified to be taxed as a real estate investment trust for the United States federal income tax purposes under the Internal Revenue Code of 1986. Ares Commercial Real Estate Management LLC operates as the manager of the company. The company was founded in 2011 and is headquartered in New York, New York.
Read More

Today's Range

Now: $15.06
Low: $14.94
High: $15.12

50 Day Range

MA: $15.32
Low: $14.44
High: $16.92

52 Week Range

Now: $15.06
Low: $8.63
High: $16.98


245,682 shs

Average Volume

573,485 shs

Market Capitalization

$707.82 million

P/E Ratio


Dividend Yield




Frequently Asked Questions

What sell-side analysts currently cover shares of Ares Commercial Real Estate?

The following sell-side analysts have issued stock ratings on Ares Commercial Real Estate in the last year: BTIG Research, Credit Suisse Group AG, JPMorgan Chase & Co., Raymond James, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for ACRE.

What is the current price target for Ares Commercial Real Estate?

4 Wall Street analysts have set twelve-month price targets for Ares Commercial Real Estate in the last year. Their average twelve-month price target is $15.13, suggesting a possible upside of 0.4%. Raymond James has the highest price target set, predicting ACRE will reach $16.50 in the next twelve months. JPMorgan Chase & Co. has the lowest price target set, forecasting a price of $13.50 for Ares Commercial Real Estate in the next year.
View the latest price targets for ACRE.

What is the current consensus analyst rating for Ares Commercial Real Estate?

Ares Commercial Real Estate currently has 1 hold rating and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ACRE will outperform the market and that investors should add to their positions of Ares Commercial Real Estate.
View the latest ratings for ACRE.

What other companies compete with Ares Commercial Real Estate?

How do I contact Ares Commercial Real Estate's investor relations team?

Ares Commercial Real Estate's physical mailing address is 245 PARK AVENUE 42ND FLOOR, NEW YORK NY, 10167. The real estate investment trust's listed phone number is 212-750-7300 and its investor relations email address is [email protected] The official website for Ares Commercial Real Estate is www.arescre.com.